Fisetin Senolytics Fill Human-Evidence Gap but Challenges Remain

Fisetin shows promise as a senolytic agent, with studies demonstrating its potential to eliminate senescent cells and enhance healthspan in aged models [PMID: 42836501]. However, despite progress in preclinical research, human trials lag in confirming these effects, highlighting a gap in current evidence [PMID: 42843464].

Research brief

Key findings

• Fisetin-derived senolytics enhance healthspan in aging mouse models [PMID: 42836501]. • Animal studies show reduced cellular senescence through apoptosis induction [PMID: 42836501]. • The translation to human trials is limited, necessitating further study [PMID: 42843464]. • Exploration of vascular impact in conditions like Giant Cell Arteritis is emerging [PMID: 42843464].

Source method

This research briefing is based on the verified PubMed records linked in the References & Citations section below.

📚References & Citations

1. Alipour M, Saeidi A, Hejazi K et al.. "12‑weeks fisetin supplementation and interval resistance with aerobic training: changes in Maresin‑1 and inflammatory markers in men with obesity: a randomized controlled trial.". Journal of the International Society of Sports Nutrition. 2026. PMID: 42218768.[PubMed ↗]

2. Yue Z, Jiang Z, Yang Y et al.. "A photo-responsive, fisetin-functionalized DNA nanocage for programmed therapy to accelerate early-stage wound healing in aged skin.". Biomaterials. 2026. PMID: 42184749.[PubMed ↗]

3. Kuddus A, Islam ME, Parvin MS et al.. "Network pharmacology and molecular docking-based investigation of flavonoids against diabetes-associated inflammation: Mechanistic insights into a multi-target therapeutic approach.". Computational biology and chemistry. 2026. PMID: 42863366.[PubMed ↗]

4. Marvisi C, Pipitone N, Franceschi C et al.. "Is there a role for senotherapeutics in the treatment of giant cell arteritis?". Ageing research reviews. 2026. PMID: 42843464.[PubMed ↗]

5. Zhang LJ, Salekeen R, Soto-Palma C et al.. "Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan.". Aging cell. 2026. PMID: 42836501.[PubMed ↗]

6. Singh A, Singh L, Dalal D. "Pharmacological mechanisms of fisetin in neurodegenerative disorders: regulation of neuroinflammatory, oxidative, and autophagic pathways.". Naunyn-Schmiedeberg's archives of pharmacology. 2026. PMID: 42417835.[PubMed ↗]